|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/54 | |
| A61P 5/00 |
| (11) | Number of the document | 2525834 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11705470.0 |
| Date of filing the European patent application | 2011-01-24 | |
| (97) | Date of publication of the European application | 2012-11-28 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/050923 |
| Date | 2011-01-24 |
| (87) | Number | WO 2011/089255 |
| Date | 2011-07-28 |
| (30) | Number | Date | Country code |
| 297305 P | 2010-01-22 | US | |
| 10151405 | 2010-01-22 | EP |
| (72) |
BEHRENS, Carsten, DK
JOHANSEN, Nils Langeland, DK
ANDERSEN, Henrik Sune, DK
N RSKOV-LAURITSEN, Leif, DK
BUCHARDT, Jens, DK
|
| (73) |
Novo Nordisk Health Care AG,
Thurgauerstrasse 36/38 8050 Zürich,
CH
|
| (54) | GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY |
| GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY |